GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » EV-to-FCF

Medical Developments International (ASX:MVP) EV-to-FCF : -6.94 (As of Mar. 27, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medical Developments International's Enterprise Value is A$48.18 Mil. Medical Developments International's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-6.94 Mil. Therefore, Medical Developments International's EV-to-FCF for today is -6.94.

The historical rank and industry rank for Medical Developments International's EV-to-FCF or its related term are showing as below:

ASX:MVP' s EV-to-FCF Range Over the Past 10 Years
Min: -265.18   Med: -4.6   Max: 196.04
Current: -8.24

During the past 13 years, the highest EV-to-FCF of Medical Developments International was 196.04. The lowest was -265.18. And the median was -4.60.

ASX:MVP's EV-to-FCF is ranked worse than
100% of 549 companies
in the Drug Manufacturers industry
Industry Median: 23.39 vs ASX:MVP: -8.24

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-27), Medical Developments International's stock price is A$0.565. Medical Developments International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.336. Therefore, Medical Developments International's PE Ratio (TTM) for today is At Loss.


Medical Developments International EV-to-FCF Historical Data

The historical data trend for Medical Developments International's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International EV-to-FCF Chart

Medical Developments International Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.08 -18.61 -5.41 -1.81 -1.97

Medical Developments International Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.81 - -1.97 -

Competitive Comparison of Medical Developments International's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Developments International's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medical Developments International's EV-to-FCF falls into.


;
;

Medical Developments International EV-to-FCF Calculation

Medical Developments International's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=48.176/-6.937
=-6.94

Medical Developments International's current Enterprise Value is A$48.18 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Developments International's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-6.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Developments International  (ASX:MVP) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medical Developments International's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.565/-0.336
=At Loss

Medical Developments International's share price for today is A$0.565.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Developments International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.336.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medical Developments International EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medical Developments International's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Developments International Business Description

Traded in Other Exchanges
Address
4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire 03-18-2022